RankAlpha logo
Back to Rankings

IDYA

IDEAYA BiosciencesA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
Current thesis
The strongest supported bull argument is that OptimUM-02 moved darovasertib closer to IDYA’s first NDA, while the company still guided to about $973 million of cash and runway into 2030, giving room to fund multiple oncology programs without an immediate financing need [#SEC-8K-2026-05-05].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -7.5.
What can break
Follow-on proof points in HLA*A2-positive mUM and other pipeline programs are still pending, leaving the stock exposed to binary data risk through H2 2026 [#SEC-8K-2026-05-05].
Momentum
88
Value
41
Sentiment
66
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $44.00 · Bull $58.00 · Bear $24.00
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-02 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $52.29
Why
Momentum88 · Δ7d -7.5
Value41 · Δ7d -0.1
Sentiment66 · Δ7d -1.0
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
88
26% active weight
Current posture
7d trendSoftening
Δ7d
-7.5
Δ21d
+21.1
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
0.0
Sentiment
66
34% active weight
Current posture
7d trendSoftening
Δ7d
-1.0
Δ21d
-18.1
Why this grade

Composite grade A. Momentum 88.4 / Value 41.1 / Sentiment 65.5

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$3.42B
Beta
0.10
Shares Out
95.08M
P/E (TTM) · Derived
-28.0
P/S (TTM)
14.26
P/FCF (TTM) · Derived
-35.58
Rev YoY
+55.4%
EPS YoY
+36.0%
Gross Margin
+98.0%
Op Margin
-97.2%
Net Debt
-$611.47M
Current Ratio
10.74
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology